InvestorNewsBreaks – IBN, BioMedWire to Collaborate with DGE for 2022 Life Science Events

January 11, 2022 14:40:43

IBN (“InvestorBrandNetwork”), an innovative corporate communications firm and content distributor, today announced that it will partner with Dynamic Global Events (“DGE”) as an official media partner for DGE’s premier 2022 life science events. BioMedWire (“BMW”), a specialized communications platform for the life sciences sector and one of the 50+ brands forming part of IBN, will also serve as an official media partner for DGE’s 2022 events. Established leader in providing successful B2B events, DGE’s primary goal is defined by its name – to serve the dynamic informational and networking needs of the pharmaceutical, biotechnology, health care, medical device and other allied industries across the life science ecosystem. With a dynamic team that leverages more than 100 years of combined B2B event experience, DGE has made a significant impact within the life sciences sector through its broad array of live, virtual and hybrid events spanning a diverse range of topics. “We are very pleased to be collaborating once again with IBN and BioMedWire,” said Elizabeth Stanislaw, MBA, senior marketing manager of Dynamic Global Events. “Their widespread syndication network and dozens of trusted brands deliver incredible visibility for our sponsors. Moreover, their multifaceted approach complements our existing strategies to reach larger audiences.”

To view the full press release, visit https://ibn.fm/GgFEH

About IBN

IBN (“InvestorBrandNetwork”) consists of financial brands introduced to the investment public over the course of 15+ years. With IBN, we have amassed a collective audience of millions of social media followers. These The distinctive investor brands aim to fulfill the unique needs of a growing base of Client Partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Through BioMedWire (“BMW”) and its affiliate brands, IBN provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) a total news coverage solution. For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.